Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Longitudinal Studies01:26

Longitudinal Studies

238
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
238
Longitudinal Research02:20

Longitudinal Research

12.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

199
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
199
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

395
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
395
Improving Translational Accuracy02:07

Improving Translational Accuracy

11.9K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
11.9K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

86
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
86

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Life Stressors in Young Americans are Linked via Asymmetric U-Shapes to Mental Health Severity.

Research square·2026
Same author

A century of suicide: Insights from long-term data in the United States.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The doctor is not in, but the Chatbot is: Utah's experience regulating mental health AI.

NPJ digital medicine·2026
Same author

Predicting the onset of internalizing disorders in early adolescence using deep learning optimized with AI.

Frontiers in psychiatry·2025
Same author

<i>RiskPath</i>: Explainable deep learning for multistep biomedical prediction in longitudinal data.

medRxiv : the preprint server for health sciences·2024
Same author

Selectively predicting the onset of ADHD, oppositional defiant disorder, and conduct disorder in early adolescence with high accuracy.

Frontiers in psychiatry·2023

Related Experiment Video

Updated: Sep 10, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

RiskPath: Explainable deep learning for multistep biomedical prediction in longitudinal data.

Nina de Lacy1, Michael Ramshaw1, Wai Yin Lam1

  • 1Department of Psychiatry, University of Utah, Salt Lake City, UT 84108, USA.

Patterns (New York, N.Y.)
|August 22, 2025
PubMed
Summary

RiskPath is a new explainable AI toolbox for disease risk stratification. It uses advanced time-series AI to predict outcomes and map predictor importance over time.

Keywords:
constrained optimizationcumulative riskexplainable deep learningfeature ablationlongitudinal cohort dataperformance-complexity trade-offsrisk pathwaystime-series learning

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

892
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

575

Related Experiment Videos

Last Updated: Sep 10, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

892
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

575

Area of Science:

  • Artificial Intelligence
  • Biomedical Informatics
  • Computational Biology

Background:

  • Multifactorial diseases arise from complex interactions of risks over time.
  • Time-series AI methods show promise for predicting disease outcomes from longitudinal data.
  • Current risk stratification tools face challenges with model complexity, size, and explainability.

Purpose of the Study:

  • To introduce RiskPath, an explainable AI toolbox for disease risk stratification.
  • To provide advanced time-series methods tailored for longitudinal cohort studies.
  • To enhance the usability and interpretability of AI models in clinical risk prediction.

Main Methods:

  • Development of RiskPath, an AI toolbox integrating advanced time-series analysis.
  • Incorporation of theoretically informed optimization for model design and performance tuning.
  • Implementation of modules for visualizing predictor importance and temporal risk factors.
  • Features for creating compact, clinically applicable models by predictor removal.

Main Results:

  • RiskPath offers explainable AI for time-series data in risk stratification.
  • The toolbox enables mapping of dynamic predictor importance throughout disease progression.
  • Users can identify critical time periods influencing disease risk.
  • Compact models can be generated with minimal impact on predictive performance.

Conclusions:

  • RiskPath addresses limitations in current AI-driven risk stratification tools.
  • The toolbox facilitates the development and deployment of interpretable AI models for longitudinal health data.
  • RiskPath supports clinical applications by providing insights into disease trajectories and risk factors.